Micardis 40 mg
Micardis 40 mg is a medicine authorised by Swissmedic under authorisation number 54780. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 1998 and the authorisation is valid without a time limit. ATC code C09CA07 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 54780 |
|---|---|
| Name | Micardis 40 mg |
| Full name | Micardis 40 mg, Tabletten |
| Authorisation holder | Boehringer Ingelheim (Schweiz) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09CA07 |
| First authorisation | 16 December 1998 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Micardis 40 mg, Tabletten | B | 16 December 1998 |
| 2 | Micardis 80 mg, Tabletten | B | 16 December 1998 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 36 | 28 | Tablette(n) | C09CA07 | 02.07.1. | B |
| 52 | 98 | Tablette(n) | C09CA07 | 02.07.1. | B |
| 79 | 28 | Tablette(n) | C09CA07 | 02.07.1. | B |
| 95 | 98 | Tablette(n) | C09CA07 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Micardis 40 mg authorised in Switzerland?
Yes. Micardis 40 mg is authorised by Swissmedic under authorisation number 54780, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Micardis 40 mg have?
Micardis 40 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Micardis 40 mg?
The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.